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Background/aim: The effects of systemic magnesium sulfate (MgSO4) on retina in preterm hypoxic-ischemic (HI) rat model are not
known. Our aim was to investigate the effects of MgSO4 on retinal ganglion cell (RGC) count, retinal ganglion cell (RGC) apoptotic
index, retinal vascular endothelial growth factor receptor-2 (VEGFR-2), and glial fibrillary acidic protein (GFAP) expressions in preterm
HI rat model.
Materials and methods: Fifteen, postnatal day (PND) 7 rat pups were divided into 3 groups: 1. Sham-operated group, 2. HI group,
and 3. MgSO4-treated HI group. The second and third groups underwent ischemia followed by exposure to hypoxia for 2 h (Vannucci
model). The first and second groups received intraperitoneal saline and the third group received intraperitoneal MgSO4. On PND 10,
eyes of the pups were evaluated for RGC count, apoptotic index, VEGFR-2, and GFAP expressions.
Results: In both HI and MgSO4-treated HI group, the mean total RGC counts were found to be significantly decreased. However, the
mean total RGC count in the MgSO4-treated HI group was significantly higher than that of the HI group. The mean apoptotic index
was found to be significantly increased in the HI group. Retinal VEGFR-2 and GFAP expressions were found to be significantly higher
in the HI group.
Conclusions: Magnesium sulfate preconditioning and treatment in preterm HI rat model might diminish apoptosis, relatively preserve
RGCs, and reduce retinal VEGFR-2 and GFAP expressions.
Key words: Hypoxia-ischemia, magnesium sulfate, neuroprotection, retina

1. Introduction
Neonatal hypoxic ischemic (HI) brain injury is a major
cause of morbidity and lifelong disabilities. Approximately
30% of newborns suffering from hypoxia/ischemia do not
survive and 20%–40% of the survivors develop chronic
neurological impairments [1]. Furthermore, hypoxic
insult to the immature retina results in death of retinal
ganglion cells (RGCs) and leads to visual impairments
in the neonate [2]. The prevalence of visual impairment
in children with HI injury ranges from 66%–94%. The
visual dysfunctions associated with HI brain injury
include strabismus, gaze palsy, nystagmus, optic atrophy,
restriction of the visual field, defective color vision, and
reduced grating acuity [3].

Several experimental models are used to mimic HI in
rodents and larger species to study the different categories
of injury seen in human infants [4]. Lack of both oxygen
(hypoxia) and blood perfusion (ischemia) must be present
for a significant period to result in brain injury comparable
to that observed in humans [5]. The Vannucci model is one
of the most widely used experimental paradigms to induce
HI injury in rat pups, resembling HI damage to the human
neonatal brain [6]. Huang et al. demonstrated the first
evidence of HI retinal damage at both pathological and
functional levels using the Vannucci model in neonatal
rats [7]. They also suggested that immature retinas are
more susceptible to HI injury as compared with those of
mature rats.
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On exposure to HI insult, both cerebral vascular
endothelial growth factor receptor-2 (VEGFR-2) and glial
fibrillary acidic protein (GFAP) expressions are known
to increase through the activation of hypoxia-inducible
factor (HIF)-1α and N-methyl-D-aspartate (NMDA)
receptors, respectively [8,9]. However, there is no study
in the literature that evaluates the retinal VEGFR-2 and
GFAP expressions in the neonatal HI rat model.
Magnesium sulfate (MgSO4) already used in the clinical
context might show prophylactic effects during pregnancy,
decreasing the incidence of preterm delivery, which in
turn reduces the possibility of in utero abnormalities that
could lead to HI events [5]. Preclinical evidence suggests
that calcium (Ca2+) influx blockage via NMDA receptor,
thus reducing excitotoxic damage, is the neuroprotective
mechanism attributed to MgSO4 [10]. Çetinkaya et al., by
using the Vannucci model, studied the effects of MgSO4
on brains of 7-day-old neonatal rats and demonstrated
that MgSO4 significantly reduced the percentage of the
infarcted brain volume and terminal deoxynucleotidyl
transferase (TdT)- mediated deoxyuridine triphosphate
(dUTP) nick-end-labeling (TUNEL) positivity [11].
Until now, the effects of MgSO4 on retina in the
neonatal HI rat model has not been studied. Our aim was
to investigate the effects of MgSO4 on RGC count, RGC
apoptotic index, retinal VEGFR-2, and GFAP expressions
in the preterm HI rat model.
2. Materials and methods
2.1. Animals
This study was approved by the Marmara University
Animal Care and Use Committee. This study was
performed in Yeditepe University, Animal Research
Laboratory between June 2019 and August 2019. Dated
pregnant Sprague-Dawley rats were housed in individual
cages in a temperature-controlled room (21 ± 1 °C) with
free access to laboratory chow and water. Rat pups were
kept in the same light cycle (lights were on from 7:00 AM to
7:00 PM). Fluorescent lights providing a more natural light
environment were used in the laboratory. The pregnant
rats were allowed to give birth spontaneously. The day of
spontaneous vaginal delivery was considered postnatal
day (PND) 1 for the pups. Offspring were reared with their
dams until the initiation of the experiments on PND 7. All
efforts were made to minimize pain and distress. Rat pups
of either sex weighing 10–18 g were used in the study.
2.2. Hypoxic-ischemic injury model and magnesium
sulfate treatment
Fifteen rat pups (PND 7) were included in the study.
They were considered to have a brain maturity roughly
corresponding to that of the human preterm fetal brain
(32–34 week-old); that is, the cerebral cortical layering is
complete, the germinal matrix is involuting and the white

matter is yet to be myelinated [12]. They were divided
randomly and equally into 3 groups: Sham-operated
(control) group, hypoxic-ischemic (HI) group, and
MgSO4-treated HI group.
Just before ischemia, the first and second groups
received intraperitoneal (IP) sterile saline (0.1 mL) and the
third group received IP 15% MgSO4 (OnPharma, Turkey)
(275 mg/kg). The dose of MgSO4 used in this study was
the same as that used in a previous experimental model
of perinatal HI brain injury [11]. This dose was slightly
higher than those used in previous experimental and
clinical studies [13–15]. We preferred to use 275 mg/kg/
dose of MgSO4 with the intent of conferring better possible
neuroprotection. Magnesium sulfate was chosen in that
it might provide preconditioning and neuroprotection
at the initial stage of HI. A schematic diagram of the
experimental protocol is shown in Figure 1.
To induce HI injury, the Vannucci model was used as
previously reported [16]. Animals were anesthetized lightly
with inhaled isoflurane (Abbott, Germany). Surgery was
performed by two investigators (SE, SI). Under operation
microscope (OMS-90 Oakland, NJ), following longitudinal
neck incision, the right common carotid artery of the
animal was exposed, isolated from the nerve and vein, and
sectioned between a double ligature with 5-0 surgical silk.
In the sham-operated group, the right common carotid
artery was only exposed. Animals exhibiting respiratory
arrest due to anesthesia or bleeding during surgery were
excluded. All the procedures were performed at room
temperature and the total time of surgery never exceeded
3 min. After the closure of the neck incision, pups were
allowed to recover for 15 min and returned to their dams
for a 2 h recuperation period before HI. The animals other
than the sham group were then placed into a chamber
partially submerged in 37 °C water to maintain a constant
thermal environment and exposed to hypoxia with a warm
humidified 8%/92% oxygen/nitrogen mixture for 2 h.
Just after the completion of HI, the second doses
of MgSO4 and sterile saline were administered
intraperitoneally to the MgSO4-treated HI group and the
HI group, respectively. Following injections, the pups were
returned to their cages and allowed to recover for 72 h with
their dams. The third dose (24 h after the second dose)
was repeated at PND 8 (Figure 1). The sham group also
received the second and third doses of IP sterile saline at
the same time as other groups.
2.3. Sacrifice, cardiac perfusion, and tissue processing
At PND 10, the rat pups were deeply anesthetized with
ketamine (Richter Pharma Ag, Austria) and xylazine
(Bayer, Germany) intraperitoneally. Transcardiac
perfusion was performed by another investigator (AC).
The right eyes of the pups were enucleated and embedded
in paraffin wax. Lenses were gently extracted and then the
eyes were serially sectioned.
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Figure 1. Experimental steps.

2.4. Estimation of the total number of retinal ganglion
cells
Cell counting was performed by an investigator (UU)
blinded to the study groups. To estimate the total RGC
count, the optical fractionator technique was used [17].
For quantification of RGCs, the Stereo Investigator v: 11.0
(Micro Bright Field, Colchester VT, USA) was used on a
PC system connected to a light microscope (Leica DM
4000B, Wetzlar, Germany). By sampling a subset of the
total number of ganglion cell nuclei within the thickness
of the retinal tissue and extrapolating, estimates are
generated for the total number of RGCs in the entire eye,
as described by West et al [18].
2.5. TUNEL assay and apoptotic index
An in situ cell death detection peroxidase (POD) kit
(Roche Diagnostics, Mannheim, Germany) was used
for the TUNEL technique and the sections were stained
according to the manufacturer’s protocol. In each sampling
frame, a counting area was designated without bias and the
apoptotic index was calculated by dividing the apoptotic
(TUNEL-positive) RGC number by the total RGC number
[19]. TUNEL-positive RGCs were counted by the same
investigator (UU) blinded to the group assignment.
2.6. Immunohistochemical staining and H scoring for
vascular endothelial growth factor receptor-2 and glial
fibrillary acidic protein
Monoclonal VEGFR-2- specific antibody (Cell signaling,
Danvers, MA, USA) and GFAP antibody (Abcam, ab7260,
Cambridge, UK) were used for immunohistochemical
staining. Immunohistochemical labeling was scored
incorporating both the intensity and the distribution of
specific staining. H score was derived according to the
modification of the previously reported method [20]. It
was performed by a single investigator (UU) blinded to
the study groups.
2.7. Statistical analysis
Statistical analyses were performed using the SPSS software
v: 21.0 (SPSS Inc., Chicago, IL, USA). The variables were
investigated using visual (histograms, probability plots)
and analytical methods (Shapiro–Wilk’s test) to determine
whether or not they are normally distributed. Since the
variables are normally distributed, descriptive analyses
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were presented using mean and standard deviation (SD).
One-way ANOVA was used to compare total RGC count,
RGC apoptotic index and H scores of VEGFR-2 and
GFAP staining between sham-operated, HI and MgSO4treated HI groups. The Levene test was used to assess the
homogeneity of the variances. When an overall significance
was observed, pairwise posthoc tests were performed
using Tukey’s test. An overall p-value of less than 0.05 was
considered to show a statistically significant result.
3. Results
Fifteen rat pups were included in the study. The weights of
the rat pups were similar for all groups. Total cell counts
and apoptotic indices of the RGCs of the study groups
were presented in Table 1. In both HI group and MgSO4treated HI group, the mean total RGC counts were found
to be significantly decreased when compared to the shamoperated (control) group. However, the mean total RGC
count in MgSO4-treated HI group was significantly higher
than that of HI group. In the HI group, the mean RGC
apoptotic index was found to be significantly increased
when compared to sham-operated (control) and MgSO4treated HI groups. However, apoptotic indices of MgSO4treated HI group and sham-operated (control) group were
similar.
Histological retinal cross-sections for total RGC
counting and TUNEL-stained apoptotic RGCs from
experimental groups were presented in Figure 2a.
H scores as an indicator of VEGFR-2 and GFAP
expressions in retinal tissue were found to be significantly
higher in HI group when compared to other groups (Table
2). On the other hand, H scores for VEGFR-2 and GFAP
were similar in sham-operated (control) and MgSO4treated HI groups. As demonstrated in Figure 2b, the
retinal layer in HI group had higher VEGFR-2 and GFAP
staining intensity in comparison to other groups.
4. Discussion
To our knowledge, this is the first preclinical study
evaluating the effects of systemic MgSO4 on developing
retina after HI insult in neonatal rats. Our results
demonstrate that MgSO4 might exhibit significant
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Table 1. Total retinal ganglion cell counts and retinal apoptotic indices of the experimental groups.
Groups

Sham-operated
(control) (n = 5)

HI
(n = 5)

MgSO4-treated HI
(n = 5)

p value

Total RGC count

240 ± 98 *,§

158 ± 65 *,†

218 ± 89 §,†

*p: 0.001
†
p: 0.001
§
p: 0.013

Apoptotic index

0.02 ± 0.01

p: 0.001
p: NS
¥
p: 0.001
ð

ð,¶

0.30 ± 0.02

ð,¥

0.06 ± 0.03

¶,¥

¶

HI: hypoxic-ischemic, MgSO4: magnesium sulfate, RGC: retinal ganglion cell. Total RGC counts were
presented as mean ± standard deviation. Apoptotic indices (TUNEL-positive cells/total cells) were
presented as mean ± standard deviation. NS: not significant. *, ð =sham vs. HI, §, ¶ =sham vs. MgSO4, †, ¥
=HI vs. MgSO4.

antiapoptotic and neuroprotective effects on the retina in
preterm HI rat model by reducing TUNEL-positive cell
count, relatively sparing RGCs, and decreasing retinal
VEGFR-2 and GFAP expressions.
In this study, the decrease in total RGC count after HI
insult in preterm rat retina could be explained by both
apoptotic and necrotic RGC death. Although we did
not study the necrotic RGC percentages, we observed a
significantly increased mean RGC apoptotic index value
in the HI group. Even though the mean total RGC count
in MgSO4-treated HI group was found to be decreased
when compared to the control group, the mean apoptotic
indices of these two groups were similar. This could
be explained by the fact that MgSO4 might have a more
distinct antiapoptotic effect than its antinecrotic effect on
preterm rat retina exposed to HI.
Excess glutamate release in HI conditions causes
excitotoxic damage to the RGCs through activation
of glutamate (NMDA) receptors [21]. Antagonism of
NMDA receptors was shown to protect against NMDAinduced retinal cell loss [22]. Magnesium, a Ca2+
antagonist, is known to antagonize NMDA-mediated
excitotoxicity, thereby limiting apoptosis. Magnesium is
also essentially and directly involved in mitochondrial
membrane stabilization, another mechanism underlying
its neuroprotective, antinecrotic, and antiapoptotic effects
[23]. Furthermore, in human and animal models, it has
been shown that MgSO4 increases cerebral blood flow
velocities through its vasodilatory effect [24,25]. This
increment in cerebral blood flow velocities might explain
the protective role of MgSO4 in ischemic events and
hypoxic brain damage. As a limitation, we could not study
the effects of systemic MgSO4 treatment on cerebral blood
flow in our HI rat model.
Hypoxia-inducible factor-1α is a hypoxia sensor and
one of the most predominant effects of HIF- induced

transcription is the induction of VEGF and its receptors
under hypoxic conditions [8]. We also found significantly
increased retinal VEGFR-2 expression in PND 7 neonatal
rats after HI insult. It is known that VEGF has different
effects on different tissues. After cerebral ischemia,
the VEGF expressed by microglial cells might have a
neurotrophic effect, however the VEGF expressed after
retinal ischemia might have a neurodegenerative effect
[26,27]. Treatments blocking/decreasing either VEGF
(anti-VEGF treatments) or VEGFR-2 expression (such as
MgSO4) could be neuroprotective in the management of
HI retinopathies.
Müller cells are responsible for the maintenance of
homeostasis in the extracellular medium of the retina
and protect the neurons by releasing neurotrophic
factors. During retinal injury, Müller cells are well
known to undergo reactive gliosis characterized by the
upregulation of GFAP [28]. Huang et al. demonstrated
HI retinal damage using the Vannucci model in preterm
neonatal rats and did not find prominent retinal GFAP
immunoreactivity until PND 21 [7]. However, in our
study, significantly increased retinal GFAP expression,
as an indicator of neuronal injury, was detected as
early as PND 10 in the HI group. Moreover, Burtrum
et al. demonstrated that excitotoxic injury stimulates
GFAP expression in PND 7 rat brains [9]. Magnesium
sulfate, by antagonizing NMDA receptor-induced GFAP
production, seems to decelerate the gliotic response of
Müller cells after HI retinal injury, thereby saving time to
retinal neurons for reparative processes.
Antenatal MgSO4 is strongly recommended for
pregnant women at risk of imminent preterm birth
before 32 weeks of gestation for fetal neuroprotection
[29]. Our experimental model was the ‘preterm’ HI rat
model, investigating the possible prophylactic role of
systemic MgSO4 in preventing both perinatal HI events
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Figure 2a. Photomicrographs demonstrating retinal ganglion cells (black arrows) (Hematoxylin and eosin staining, the magnification
is x10) and apoptotic retinal ganglion cells (white arrow heads) (TUNEL staining, the magnification is x100) of the rat pups from
experimental groups: Sham, HI and MgSO4.

Figure 2b. Vascular endothelial growth factor receptor-2 (VEGFR-2) and glial fibrillary acidic protein (GFAP) staining images of
the representative retinal sections of the rat pups from experimental groups: Sham, HI and MgSO4. VEGFR-2 staining intensity
was found increased in the retina of the HI group (brownish color) (white arrow). The magnification is x20. GFAP staining
intensity was found increased in the retina ganglion cell layer of the HI group (brownish color) (black arrow). The magnification
is x100

and retinal injury. We, therefore, administered the first
dose of MgSO4 just before ischemia. However, most
experimental studies have failed to confirm that MgSO4
is neuroprotective if given immediately before, during
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or after HI [30,31]. Koning et al. demonstrated that via
providing mitochondrial protection, MgSO4 induces
strong preconditioning, i.e. it reduces the vulnerability of
the immature brain to a subsequent severe insult when
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Table 2. H scores of experimental groups for vascular endothelial growth factor receptor-2 and glial fibrillary
acidic protein.
Groups

Sham-operated
(control) *,† (n = 5)

HI *,§
(n = 5)

MgSO4-treated HI†,§
(n = 5)

p value

H score for VEGFR-2

29.6 ± 5.4

56 ± 4.5

33.6 ± 4.3

*p: 0.001
†
p: NS
§
p: 0.001

H score for GFAP

27.4 ± 4.1

56.3 ± 2.3

31.3 ± 4

*p: 0.001
†
p: NS
§
p: 0.001

HI: hypoxic-ischemic, MgSO4: magnesium sulfate, VEGFR-2: vascular endothelial growth factor receptor-2,
GFAP: glial fibrillary acidic protein. H scores for VEGFR-2 and GFAP were presented as mean ± standard
deviation. *=sham vs. HI, p: 0.001, †=sham vs. MgSO4, p: NS (not significant), §=HI vs. MgSO4, p: 0.001.

administered 6 days to 12 h before the induction of HI
in the PND 7 rat [32]. The MgSO4 dose was 1.1 g/kg as
a bolus in that study, whereas we administered 275 mg/
kg/dose as three doses, the first just before ischemia and
the remaining two after hypoxia. The total MgSO4 dose
was less (three-fourths) than that of Koning’s study. As
an extension of the brain, the retinas of PND 7 rats in
our study were found to be relatively spared after HI
insult, even though MgSO4 was administered just before
HI. Moreover, we unfortunately could not investigate the
dose-dependent effect of MgSO4 on retina in this preterm
HI rat model. This was a limitation of our study.
A common hallmark in retinal ischemia models is the
progressive degeneration and final neuronal loss in the
ganglion cell layer (GCL) [7]. Therefore, we focussed on
GCL in our study. We did not evaluate the other retinal
(inner plexiform, inner nuclear, outer plexiform, and
outer nuclear) layers and optic nerve at the pathological
level. Furthermore, we could not study HI retinal damage
and effects of MgSO4 treatment at the functional level
with electroretinography. Our results might reflect only
short-term effects of MgSO4 on retinas of HI rat pups.

We did not study the long-term effects. Also, the results
of this experimental study could not be totally applied on
human beings. These are limitations of our study.
In conclusion, systemic MgSO4 preconditioning and
treatment in the preterm HI rat model might diminish
apoptosis, relatively preserve RGCs, and reduce HIinduced retinal VEGFR-2 and GFAP expressions,
suggesting that it could be a therapeutic agent in
attenuating the HI insult to the developing retina.
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